Form D · Biotechnology
INVIVO THERAPEUTICS HOLDINGS CORP.
Cambridge, MA · CIK 0001292519
Offering snapshot reported Oct 14, 2022 · SEC filing
- Reported sold
- $6.25M Offering amount: $6.25M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 11, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 14, 2022 | Initial | $6,249,999 | No comparison | 1 | SEC filing |
| Apr 28, 2020 | Initial | $3,022,576 | No comparison | 8 | SEC filing |
| Nov 9, 2010 | Amendment | $10,514,097 | No comparison | 121 | SEC filing |
| Oct 6, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 22, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $531K
- Finders' fees
- $0
- Form D file number
- 021-461817
Private Placement of (i) pre-funded warrants to purchase up to 1,190,476 shares of common stock for a purchase price of $5.2499 per pre-funded warrant and (ii) preferred investment options to purchase up to 1,714,286 shares of common stock
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Oct 14, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Christopher | Executive |
| Peter L. Coker | Director, Executive |
| Heather Hamel | Executive |
| Daniel Marshak | Director |
| C. Ann Merrifield | Director |
| Christina Morrison | Director |
| George Nolen | Director |
| Christi M Pedra | Director |
| Peter A. Reichard | Director, Executive |
| Frank M Reynolds | Director, Executive |
| Richard Roberts | Director |
| Robert Rosenthal | Director |
| Adam K Stern | Director |
| Richard Toselli | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Kendall Square Suite B14402
Cambridge, MA, 02139
Cambridge, MA, 02139